We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+1.86%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$54.7B
AUM Growth
+$1.45B
Cap. Flow
+$1.02B
Cap. Flow %
1.86%
Top 10 Hldgs %
17.33%
Holding
3,009
New
39
Increased
2,170
Reduced
725
Closed
55

Top Buys

Rank Stock Value
1
FIS icon
Fidelity National Information Services
FIS
+$65.3M
2
GPN icon
Global Payments
GPN
+$40.3M
3
MSFT icon
Microsoft
MSFT
+$37.9M
4
LHX icon
L3Harris
LHX
+$32.8M
5
AMZN icon
Amazon
AMZN
+$32.5M

Sector Composition

Rank Sector Weight
1 Technology 18.64%
2 Financials 15.56%
3 Healthcare 12.85%
4 Consumer Discretionary 10.31%
5 Industrials 10.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SRRK icon
2776
Scholar Rock
SRRK
$5.49B
$175K ﹤0.01%
19,553
+390
+2% +$4.66K
TWIN icon
2777
Twin Disc
TWIN
$334M
$175K ﹤0.01%
16,518
+1,368
+9% +$16.2K
OSG
2778
DELISTED
Overseas Shipholding Group Inc.
OSG
$175K ﹤0.01%
99,942
+8,818
+10% +$15.8K
MUFG icon
2779
Mitsubishi UFJ Financial
MUFG
$254B
$174K ﹤0.01%
34,318
+13,080
+62% +$64.1K
THOR
2780
DELISTED
Synthorx, Inc. Common Stock
THOR
$174K ﹤0.01%
+10,702
New +$179K
OVLY icon
2781
Oak Valley Bancorp
OVLY
$283M
$173K ﹤0.01%
+10,302
New +$185K
ACET icon
2782
Adicet Bio
ACET
$86.4M
$172K ﹤0.01%
174
+19
+12% +$21.2K
SNDX icon
2783
Syndax Pharmaceuticals
SNDX
$1.69B
$171K ﹤0.01%
22,851
-140
-0.6% -$1.27K
MCRB icon
2784
Seres Therapeutics
MCRB
$48.7M
$170K ﹤0.01%
2,117
+275
+15% +$18.2K
PYX
2785
DELISTED
Pyxus International, Inc.
PYX
$170K ﹤0.01%
12,978
+1,162
+10% +$16.8K
VSI
2786
DELISTED
Vitamin Shoppe Inc.
VSI
$170K ﹤0.01%
26,094
+539
+2% +$3.03K
RJET
2787
Republic Airways Holdings
RJET
$990M
$169K ﹤0.01%
1,667
+89
+6% +$10.8K
NVAX icon
2788
Novavax
NVAX
$1.26B
$168K ﹤0.01%
33,428
+3,118
+10% +$17.1K
AMSC icon
2789
American Superconductor
AMSC
$1.62B
$167K ﹤0.01%
21,330
+2,070
+11% +$17.6K
NDLS icon
2790
Noodles & Co
NDLS
$111M
$167K ﹤0.01%
3,681
-34
-0.9% -$1.82K
EMWP
2791
DELISTED
Eros Media World PLC
EMWP
$167K ﹤0.01%
4,364
+1,910
+78% +$67.9K
GWRS icon
2792
Global Water Resources
GWRS
$210M
$166K ﹤0.01%
14,020
-125
-0.9% -$1.48K
LCUT icon
2793
Lifetime Brands
LCUT
$195M
$166K ﹤0.01%
18,770
+1,649
+10% +$14.3K
YELL
2794
DELISTED
Yellow Corporation Common Stock
YELL
$165K ﹤0.01%
54,700
+5,231
+11% +$16.5K
USX
2795
DELISTED
U.S. Xpress Enterprises, Inc. Class A Common Stock
USX
$164K ﹤0.01%
34,118
+2,797
+9% +$12.7K
TCRR
2796
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
$162K ﹤0.01%
+10,790
New +$168K
CSLT
2797
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
$162K ﹤0.01%
115,144
-775
-0.7% -$1.54K
ALDX icon
2798
Aldeyra Therapeutics
ALDX
$92.3M
$161K ﹤0.01%
30,641
+706
+2% +$3.8K
VIA
2799
DELISTED
Via Renewables, Inc. Class A Common Stock
VIA
$160K ﹤0.01%
3,024
+11
+0.4% +$580
SPRO icon
2800
Spero Therapeutics
SPRO
$71.2M
$159K ﹤0.01%
15,042
+1,481
+11% +$15.6K

Similar funds

RhumbLine Advisers's Q3 2019 Portfolio in Review

As of Q3 2019, RhumbLine Advisers held 3,009 positions worth $54.7B, up 2.7% from $53.3B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Trading was light in Q3 2019: portfolio turnover was 3.1%. RhumbLine Advisers opened 39 new positions and exited 55, leaving the 3,009-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Financials and Healthcare.

  • RhumbLine Advisers's largest Q3 2019 buy was Avantor: 187,780 shares worth $2.76M.
  • RhumbLine Advisers added most to Fidelity National Information Services in Q3 2019, an estimated $65.3M increase.
  • RhumbLine Advisers's biggest Q3 2019 reduction was Leidos, cutting an estimated $15M.
  • RhumbLine Advisers fully exited Anadarko Petroleum in Q3 2019, selling an estimated $64.3M.
  • RhumbLine Advisers's ten largest holdings make up 17% of its $54.7B portfolio in Q3 2019.
  • RhumbLine Advisers opened 39 new positions and closed 55 in Q3 2019.
  • RhumbLine Advisers's portfolio value rose 2.7% quarter-over-quarter to $54.7B.

Based on RhumbLine Advisers's 13F filing for Q3 2019, filed 23 Oct 2019.